Missouri appeals court tosses $55 million J&J talc-powder verdict
(Reuters) – A Missouri appeals court on Friday threw out a $55 million verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer…
Amazon to buy PillPack in potentially disruptive drug retail push
(Reuters) – Amazon.com Inc said on Thursday it would buy small online pharmacy PillPack, a move that will put the world’s biggest online retailer in direct competition with drugstore chains,…
U.S. charges hundreds in major healthcare fraud, opioid crackdown
(Reuters) – The U.S. Justice Department on Thursday announced charges against 601 people including doctors for taking part in healthcare frauds that resulted in over $2 billion in losses and…
Ex-Akebia employee jailed for night as insider trading trial starts
BOSTON (Reuters) – A former Akebia Therapeutics Inc (AKBA.O) employee accused of engaging in an insider trading scheme must spend a night in jail after he violated a U.S. judge’s…
U.S. medical device firm electroCore IPO price set at $15 per share
(Reuters) – U.S. medical device maker electroCore Llc’s initial public offering is expected to price at $15 per share, Chief Executive Officer Frank Amato told Reuters on Thursday. ElectroCore, which…
After law change, Greek medicinal users hope to enter cannabis business
XYLOKASTRO, Greece (Reuters) – Konstantinos Syros turned to cannabis 26 years ago after a motorcycle accident left him with deformed arm and debilitating pain that conventional treatments could not assuage.…
Theranos founder Holmes, former president indicted for fraud
(Reuters) – Theranos Inc founder Elizabeth Holmes and the embattled blood-testing company’s former president were indicted on charges that they engaged in schemes to defraud investors, doctors and patients, the…
Theranos founder Holmes, former president indicted for fraud
(Reuters) – Theranos Inc founder Elizabeth Holmes and the embattled blood-testing company’s former president were indicted on charges that they engaged in schemes to defraud investors, doctors and patients, the…
GSK’s two-drug HIV treatment meets main goal in late stage studies
(Reuters) – GlaxoSmithKline’s two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies, scoring key points in its rivalry with Gilead in the…
Medical device maker Stryker makes takeover approach to Boston Scientific: WSJ
(Reuters) – Medical device maker Stryker Corp has made a takeover approach to rival Boston Scientific Corp, the Wall Street Journal reported on Monday, a combination that would give Stryker…